Stem Cell Therapies Market
Stem cells are undifferentiated biological cells, and having remarkable potential to divide into any kind of other cells. When a stem cell divides, each new cell will be a new stem cell or it will be like another cell which is having specific function such as a muscle cell, a red blood cell, brain cell and some other cells.
There are two types of stem cells
Embryonic cells
Adult stem or Somatic cells
Stem cells harvested from umbilical cord blood just after birth. And this cells can be stored in specific conditions. Stem cells also can be harvest from bone marrow, adipose tissue.
Embryonic cells can differentiate into ectoderm, endoderm and mesoderm in developing stage. Stem cells used in the therapies and surgeries for regeneration of organisms or cells, tissues.
Stem cells are used for the treatment of Gastro intestine diseases, Metabolic diseases, Immune system diseases, Central Nervous System diseases, Cardiovascular diseases, Wounds and injuries, Eye diseases, Musculoskeletal disorders.
Harvesting of Adult cell is somewhat difficult compare to embryonic cells. Because Adult cells available in the own body and it is somewhat difficult to harvest.
Stem Cell Therapies Market: Drivers and Restraints
Technology advancements in healthcare now curing life threatening diseases and giving promising results. Stem Cell Therapies having so many advantages like regenerating the other cells and body organisms. This is the main driver for this market. These therapies are useful in many life threatening treatments. Increasing the prevalence rate of diseases are driven the Stem Cell Therapies market, it is also driven by increasing technology advancements in healthcare. Technological advancements in healthcare now saving the population from life threatening complications.
Increasing funding from government, private organizations and increasing the Companies focus on Stem cell therapies are also driven this market
However, Collecting the Embryonic Stem cells are easy but Collecting Adult Stem cell or Somatic Stem cells are difficult and also we have to take more precautions for storing the collected stem cells.
Stem Cell Therapies Market: Segmentation
Stem Cell Therapies are segmented into following types
Based on treatment:
Allogeneic stem cell therapy
Autologous stem cell therapy
Based on application:
Gastro intestine diseases
Metabolic diseases
Immune system diseases
Central Nervous System diseases
Cardiovascular diseases
Wounds and injuries
Eye diseases
Musculoskeletal disorders
Based on End User:
Hospitals
Ambulatory Surgical centers
Stem Cell Therapies Market: Overview
With rapid technological advantage in healthcare and its promising results, the use of Stem Cell Therapies will increase and the market is expected to have a double digit growth in the forecast period (2015-2025).
Stem Cell Therapies Market: Region- wise Outlook
Depending on geographic regions, the global Stem Cell Therapies market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa.
The use of Stem Cell Therapies is high in North America because it is highly developed region, having good technological advancements in healthcare setup and people are having good awareness about health care. In Asia pacific region china and India also having rapid growth in health care set up. Europe also having good growth in this market.
Stem Cell Therapies Market: Key Players
Some of the key players in this market are
Mesoblast Ltd.,
Roslin Cells,
Regeneus Ltd,
ReNeuron Group plc,
International Stem Cell Corporation.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
The report covers exhaustive analysis on:
Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes
North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, N. Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Report Highlights:
Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.
- 1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand-side Trends
- 1.3. Supply-side Trends
- 1.4. Technology Roadmap Analysis
- 1.5. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Market Background
- 3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
- 3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
- 3.3. Opportunity Map Analysis
- 3.4. Investment Feasibility Matrix
- 3.5. PESTLE and Porter’s Analysis
- 3.6. Regulatory Landscape
- 3.6.1. By Key Regions
- 3.6.2. By Key Countries
- 3.7. Regional Parent Market Outlook
- 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
- 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
- 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
- 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Therapy Type
- 5.1. Introduction / Key Findings
- 5.2. Historical Market Size Value (US$ Mn) Analysis By Therapy Type, 2017-2021
- 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Therapy Type, 2022-2032
- 5.3.1. Allogeneic Therapy
- 5.3.2. Autologous Therapy
- 5.4. Y-o-Y Growth Trend Analysis By Therapy Type, 2017-2021
- 5.5. Absolute $ Opportunity Analysis By Therapy Type, 2022-2032
- Deep-dive segmentation will be available in the sample on request
- 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Indication
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021
- 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032
- 6.3.1. Autoimmune Diseases
- 6.3.2. Musculoskeletal Disorders
- 6.3.3. Acute Graft Host Disease
- 6.3.4. Trauma Injuries
- 6.3.5. Others
- 6.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021
- 6.5. Absolute $ Opportunity Analysis By Indication, 2022-2032
- Deep-dive segmentation will be available in the sample on request
- 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User
- 7.1. Introduction / Key Findings
- 7.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
- 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
- 7.3.1. Hospitals
- 7.3.2. Acute Care Facilities
- 7.3.3. Specialized Clinics
- 7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
- 7.5. Absolute $ Opportunity Analysis By End User, 2022-2032
- Deep-dive segmentation will be available in the sample on request
- 8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Stem Cell Type
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size Value (US$ Mn) Analysis By Stem Cell Type, 2017-2021
- 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Stem Cell Type, 2022-2032
- 8.3.1. Embryonic Stem Cells
- 8.3.2. Tissue-specific Stem Cells
- 8.3.3. Mesenchymal Stem Cells
- 8.3.4. Induced Pluripotent Stem Cells
- 8.4. Y-o-Y Growth Trend Analysis By Stem Cell Type, 2017-2021
- 8.5. Absolute $ Opportunity Analysis By Stem Cell Type, 2022-2032
- Deep-dive segmentation will be available in the sample on request
- 9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
- 9.1. Introduction
- 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
- 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
- 9.3.1. North America
- 9.3.2. Latin America
- 9.3.3. Europe
- 9.3.4. East Asia
- 9.3.5. South Asia & Pacific
- 9.3.6. MEA
- 9.4. Market Attractiveness Analysis By Region
- 10. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 10.2.1. By Country
- 10.2.1.1. U.K.
- 10.2.1.2. Canada
- 10.2.2. By Therapy Type
- 10.2.3. By Indication
- 10.2.4. By End User
- 10.2.5. By Stem Cell Type
- 10.3. Market Attractiveness Analysis
- 10.3.1. By Country
- 10.3.2. By Therapy Type
- 10.3.3. By Indication
- 10.3.4. By End User
- 10.3.5. By Stem Cell Type
- 10.4. Key Takeaways
- 11. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 11.2.1. By Country
- 11.2.1.1. Brazil
- 11.2.1.2. Mexico
- 11.2.1.3. Rest of Latin America
- 11.2.2. By Therapy Type
- 11.2.3. By Indication
- 11.2.4. By End User
- 11.2.5. By Stem Cell Type
- 11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Therapy Type
- 11.3.3. By Indication
- 11.3.4. By End User
- 11.3.5. By Stem Cell Type
- 11.4. Key Takeaways
- 12. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 12.2.1. By Country
- 12.2.1.1. Germany
- 12.2.1.2. U.K.
- 12.2.1.3. France
- 12.2.1.4. Spain
- 12.2.1.5. Italy
- 12.2.1.6. Rest of Europe
- 12.2.2. By Therapy Type
- 12.2.3. By Indication
- 12.2.4. By End User
- 12.2.5. By Stem Cell Type
- 12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Therapy Type
- 12.3.3. By Indication
- 12.3.4. By End User
- 12.3.5. By Stem Cell Type
- 12.4. Key Takeaways
- 13. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 13.2.1. By Country
- 13.2.1.1. China
- 13.2.1.2. Japan
- 13.2.1.3. South Korea
- 13.2.2. By Therapy Type
- 13.2.3. By Indication
- 13.2.4. By End User
- 13.2.5. By Stem Cell Type
- 13.3. Market Attractiveness Analysis
- 13.3.1. By Country
- 13.3.2. By Therapy Type
- 13.3.3. By Indication
- 13.3.4. By End User
- 13.3.5. By Stem Cell Type
- 13.4. Key Takeaways
- 14. South Asia & Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 14.2.1. By Country
- 14.2.1.1. India
- 14.2.1.2. Thailand
- 14.2.1.3. Indonesia
- 14.2.1.4. Malaysia
- 14.2.1.5. Singapore
- 14.2.1.6. Australia
- 14.2.1.7. New Zealand
- 14.2.1.8. Rest of South Asia & Pacific
- 14.2.2. By Therapy Type
- 14.2.3. By Indication
- 14.2.4. By End User
- 14.2.5. By Stem Cell Type
- 14.3. Market Attractiveness Analysis
- 14.3.1. By Country
- 14.3.2. By Therapy Type
- 14.3.3. By Indication
- 14.3.4. By End User
- 14.3.5. By Stem Cell Type
- 14.4. Key Takeaways
- 15. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 15.2.1. By Country
- 15.2.1.1. GCC Countries
- 15.2.1.2. South Africa
- 15.2.1.3. Israel
- 15.2.1.4. Rest of MEA
- 15.2.2. By Therapy Type
- 15.2.3. By Indication
- 15.2.4. By End User
- 15.2.5. By Stem Cell Type
- 15.3. Market Attractiveness Analysis
- 15.3.1. By Country
- 15.3.2. By Therapy Type
- 15.3.3. By Indication
- 15.3.4. By End User
- 15.3.5. By Stem Cell Type
- 15.4. Key Takeaways
- 16. Key Countries Market Analysis
- 16.1. U.K.
- 16.1.1. Pricing Analysis
- 16.1.2. Market Share Analysis, 2021
- 16.1.2.1. By Therapy Type
- 16.1.2.2. By Indication
- 16.1.2.3. By End User
- 16.1.2.4. By Stem Cell Type
- 16.2. Canada
- 16.2.1. Pricing Analysis
- 16.2.2. Market Share Analysis, 2021
- 16.2.2.1. By Therapy Type
- 16.2.2.2. By Indication
- 16.2.2.3. By End User
- 16.2.2.4. By Stem Cell Type
- 16.3. Brazil
- 16.3.1. Pricing Analysis
- 16.3.2. Market Share Analysis, 2021
- 16.3.2.1. By Therapy Type
- 16.3.2.2. By Indication
- 16.3.2.3. By End User
- 16.3.2.4. By Stem Cell Type
- 16.4. Mexico
- 16.4.1. Pricing Analysis
- 16.4.2. Market Share Analysis, 2021
- 16.4.2.1. By Therapy Type
- 16.4.2.2. By Indication
- 16.4.2.3. By End User
- 16.4.2.4. By Stem Cell Type
- 16.5. Germany
- 16.5.1. Pricing Analysis
- 16.5.2. Market Share Analysis, 2021
- 16.5.2.1. By Therapy Type
- 16.5.2.2. By Indication
- 16.5.2.3. By End User
- 16.5.2.4. By Stem Cell Type
- 16.6. U.K.
- 16.6.1. Pricing Analysis
- 16.6.2. Market Share Analysis, 2021
- 16.6.2.1. By Therapy Type
- 16.6.2.2. By Indication
- 16.6.2.3. By End User
- 16.6.2.4. By Stem Cell Type
- 16.7. France
- 16.7.1. Pricing Analysis
- 16.7.2. Market Share Analysis, 2021
- 16.7.2.1. By Therapy Type
- 16.7.2.2. By Indication
- 16.7.2.3. By End User
- 16.7.2.4. By Stem Cell Type
- 16.8. Spain
- 16.8.1. Pricing Analysis
- 16.8.2. Market Share Analysis, 2021
- 16.8.2.1. By Therapy Type
- 16.8.2.2. By Indication
- 16.8.2.3. By End User
- 16.8.2.4. By Stem Cell Type
- 16.9. Italy
- 16.9.1. Pricing Analysis
- 16.9.2. Market Share Analysis, 2021
- 16.9.2.1. By Therapy Type
- 16.9.2.2. By Indication
- 16.9.2.3. By End User
- 16.9.2.4. By Stem Cell Type
- 16.10. China
- 16.10.1. Pricing Analysis
- 16.10.2. Market Share Analysis, 2021
- 16.10.2.1. By Therapy Type
- 16.10.2.2. By Indication
- 16.10.2.3. By End User
- 16.10.2.4. By Stem Cell Type
- 16.11. Japan
- 16.11.1. Pricing Analysis
- 16.11.2. Market Share Analysis, 2021
- 16.11.2.1. By Therapy Type
- 16.11.2.2. By Indication
- 16.11.2.3. By End User
- 16.11.2.4. By Stem Cell Type
- 16.12. South Korea
- 16.12.1. Pricing Analysis
- 16.12.2. Market Share Analysis, 2021
- 16.12.2.1. By Therapy Type
- 16.12.2.2. By Indication
- 16.12.2.3. By End User
- 16.12.2.4. By Stem Cell Type
- 16.13. India
- 16.13.1. Pricing Analysis
- 16.13.2. Market Share Analysis, 2021
- 16.13.2.1. By Therapy Type
- 16.13.2.2. By Indication
- 16.13.2.3. By End User
- 16.13.2.4. By Stem Cell Type
- 16.14. Thailand
- 16.14.1. Pricing Analysis
- 16.14.2. Market Share Analysis, 2021
- 16.14.2.1. By Therapy Type
- 16.14.2.2. By Indication
- 16.14.2.3. By End User
- 16.14.2.4. By Stem Cell Type
- 16.15. Indonesia
- 16.15.1. Pricing Analysis
- 16.15.2. Market Share Analysis, 2021
- 16.15.2.1. By Therapy Type
- 16.15.2.2. By Indication
- 16.15.2.3. By End User
- 16.15.2.4. By Stem Cell Type
- 16.16. Malaysia
- 16.16.1. Pricing Analysis
- 16.16.2. Market Share Analysis, 2021
- 16.16.2.1. By Therapy Type
- 16.16.2.2. By Indication
- 16.16.2.3. By End User
- 16.16.2.4. By Stem Cell Type
- 16.17. Singapore
- 16.17.1. Pricing Analysis
- 16.17.2. Market Share Analysis, 2021
- 16.17.2.1. By Therapy Type
- 16.17.2.2. By Indication
- 16.17.2.3. By End User
- 16.17.2.4. By Stem Cell Type
- 16.18. Australia
- 16.18.1. Pricing Analysis
- 16.18.2. Market Share Analysis, 2021
- 16.18.2.1. By Therapy Type
- 16.18.2.2. By Indication
- 16.18.2.3. By End User
- 16.18.2.4. By Stem Cell Type
- 16.19. New Zealand
- 16.19.1. Pricing Analysis
- 16.19.2. Market Share Analysis, 2021
- 16.19.2.1. By Therapy Type
- 16.19.2.2. By Indication
- 16.19.2.3. By End User
- 16.19.2.4. By Stem Cell Type
- 16.20. GCC Countries
- 16.20.1. Pricing Analysis
- 16.20.2. Market Share Analysis, 2021
- 16.20.2.1. By Therapy Type
- 16.20.2.2. By Indication
- 16.20.2.3. By End User
- 16.20.2.4. By Stem Cell Type
- 16.21. South Africa
- 16.21.1. Pricing Analysis
- 16.21.2. Market Share Analysis, 2021
- 16.21.2.1. By Therapy Type
- 16.21.2.2. By Indication
- 16.21.2.3. By End User
- 16.21.2.4. By Stem Cell Type
- 16.22. Israel
- 16.22.1. Pricing Analysis
- 16.22.2. Market Share Analysis, 2021
- 16.22.2.1. By Therapy Type
- 16.22.2.2. By Indication
- 16.22.2.3. By End User
- 16.22.2.4. By Stem Cell Type
- 17. Market Structure Analysis
- 17.1. Competition Dashboard
- 17.2. Competition Benchmarking
- 17.3. Market Share Analysis of Top Players
- 17.3.1. By Regional
- 17.3.2. By Therapy Type
- 17.3.3. By Indication
- 17.3.4. By End User
- 17.3.5. By Stem Cell Type
- 18. Competition Analysis
- 18.1. Competition Deep Dive
- 18.1.1. Vericel Corporation
- 18.1.1.1. Overview
- 18.1.1.2. Product Portfolio
- 18.1.1.3. Profitability by Market Segments
- 18.1.1.4. Sales Footprint
- 18.1.1.5. Strategy Overview
- 18.1.1.5.1. Marketing Strategy
- 18.1.2. Cyagen Biosciences, Inc.
- 18.1.2.1. Overview
- 18.1.2.2. Product Portfolio
- 18.1.2.3. Profitability by Market Segments
- 18.1.2.4. Sales Footprint
- 18.1.2.5. Strategy Overview
- 18.1.2.5.1. Marketing Strategy
- 18.1.3. Stemcell Technologies Inc.
- 18.1.3.1. Overview
- 18.1.3.2. Product Portfolio
- 18.1.3.3. Profitability by Market Segments
- 18.1.3.4. Sales Footprint
- 18.1.3.5. Strategy Overview
- 18.1.3.5.1. Marketing Strategy
- 18.1.4. Celegene Corporation
- 18.1.4.1. Overview
- 18.1.4.2. Product Portfolio
- 18.1.4.3. Profitability by Market Segments
- 18.1.4.4. Sales Footprint
- 18.1.4.5. Strategy Overview
- 18.1.4.5.1. Marketing Strategy
- 18.1.5. Cellular Dynamics International
- 18.1.5.1. Overview
- 18.1.5.2. Product Portfolio
- 18.1.5.3. Profitability by Market Segments
- 18.1.5.4. Sales Footprint
- 18.1.5.5. Strategy Overview
- 18.1.5.5.1. Marketing Strategy
- 18.1.6. Cytori Therapeutics, Inc.
- 18.1.6.1. Overview
- 18.1.6.2. Product Portfolio
- 18.1.6.3. Profitability by Market Segments
- 18.1.6.4. Sales Footprint
- 18.1.6.5. Strategy Overview
- 18.1.6.5.1. Marketing Strategy
- 18.1.7. Fibrocell Science, Inc.
- 18.1.7.1. Overview
- 18.1.7.2. Product Portfolio
- 18.1.7.3. Profitability by Market Segments
- 18.1.7.4. Sales Footprint
- 18.1.7.5. Strategy Overview
- 18.1.7.5.1. Marketing Strategy
- 18.1.8. Mesoblast Ltd
- 18.1.8.1. Overview
- 18.1.8.2. Product Portfolio
- 18.1.8.3. Profitability by Market Segments
- 18.1.8.4. Sales Footprint
- 18.1.8.5. Strategy Overview
- 18.1.8.5.1. Marketing Strategy
- 18.1.9. Regeneus Ltd
- 18.1.9.1. Overview
- 18.1.9.2. Product Portfolio
- 18.1.9.3. Profitability by Market Segments
- 18.1.9.4. Sales Footprint
- 18.1.9.5. Strategy Overview
- 18.1.9.5.1. Marketing Strategy
- 18.1.10. EMD Millipore Corporation
- 18.1.10.1. Overview
- 18.1.10.2. Product Portfolio
- 18.1.10.3. Profitability by Market Segments
- 18.1.10.4. Sales Footprint
- 18.1.10.5. Strategy Overview
- 18.1.10.5.1. Marketing Strategy
- 18.1.11. ReNeuron Group plc
- 18.1.11.1. Overview
- 18.1.11.2. Product Portfolio
- 18.1.11.3. Profitability by Market Segments
- 18.1.11.4. Sales Footprint
- 18.1.11.5. Strategy Overview
- 18.1.11.5.1. Marketing Strategy
- 18.1.12. International Stem Cell Corporation
- 18.1.12.1. Overview
- 18.1.12.2. Product Portfolio
- 18.1.12.3. Profitability by Market Segments
- 18.1.12.4. Sales Footprint
- 18.1.12.5. Strategy Overview
- 18.1.12.5.1. Marketing Strategy
- 19. Assumptions & Acronyms Used
- 20. Research Methodology
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook